Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: effect of dose and physicochemical properties.
Hesperidin, a flavanone glycoside, and its aglycone hesperetin are potential candidates for the treatment of diabetic retinopathy and macular edema. The objective of this study was to delineate vitreal pharmacokinetics of hesperidin and hesperetin and the hydrophilic derivative glucosyl hesperidin (hesperidin G) following intravitreal administration in anaesthetized rabbits. Concentration changes in vitreous humor were monitored using microdialysis sampling procedure. All three molecules were administered intravitreally at three dose levels (50 µL injection volume containing 1.5, 4.5, and 15 µg of the drug, resulting in a final vitreal concentration of 1, 3, and 10 µg/mL). Vitreal microdialysis samples were collected every 20 min over a period of 10 h. All three molecules exhibited linear pharmacokinetics within the dose range tested because area under the curve and maximum concentration (C(max) ) increased linearly with increasing dose and a significant difference in the elimination parameters such as clearance or half-life was not observed. The vitreal elimination half-life of these three compounds was observed to correlate with the molecular weight and lipophilicity of the molecules. The findings from this study provide practical information that will be useful in the future design of ocular drug delivery strategies for bioflavonoids.
Department of Pharmaceutics, The University of Mississippi, University, Mississippi 38677, USA.
Ramesh
R
Srirangam
Ketan
K
Hippalgaonkar
Soumyajit
S
Majumdar
D000818:Animals; D004305:Dose-Response Relationship, Drug; D005960:Glucosides / Q000737:chemistry / Q000493:pharmacokinetics*; D006569:Hesperidin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics*; D008297:Male; D011817:Rabbits; D014822:Vitreous Body / Q000378:metabolism*
D005960:Glucosides; C487382:glucosyl hesperidin; D006569:Hesperidin; C013015:hesperetin